Compile Data Set for Download or QSAR
Report error Found 53 Enz. Inhib. hit(s) with all data for entry = 10948
TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580439(US11491148, Compound C33R* | US11491148, Compound ...)
Affinity DataEC50:  3nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580406(US11491148, Compound C16)
Affinity DataEC50:  6nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580427(US11491148, Compound C31R* | US11491148, Compound ...)
Affinity DataEC50:  7nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580447(US11491148, Compound C36)
Affinity DataEC50: <10nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580407(US11491148, Compound C17)
Affinity DataEC50:  10nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580445(US11491148, Compound C35 | US11491148, Compound C3...)
Affinity DataEC50:  11nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580207(US11491148, Compound C3)
Affinity DataEC50:  11nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580420(US11491148, Compound C27)
Affinity DataEC50:  12nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580408(US11491148, Compound C18)
Affinity DataEC50:  12nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580450(US11491148, Compound C38)
Affinity DataEC50:  12nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580411(US11491148, Compound C21)
Affinity DataEC50:  12nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580410(US11491148, Compound C20)
Affinity DataEC50:  12nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580414(US11491148, Compound C24)
Affinity DataEC50:  12nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580448(US11491148, Compound C37R*)
Affinity DataEC50:  14nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580402(US11491148, Compound C15)
Affinity DataEC50:  14nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580419(US11491148, Compound C26 | US11491148, Compound C2...)
Affinity DataEC50:  14nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580413(US11491148, Compound C23)
Affinity DataEC50:  16nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580416(US11491148, Compound C25R*)
Affinity DataEC50:  17nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580401(US11491148, Compound C14)
Affinity DataEC50:  19nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580409(US11491148, Compound C19)
Affinity DataEC50:  19nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580427(US11491148, Compound C31R* | US11491148, Compound ...)
Affinity DataEC50:  21nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580412(US11491148, Compound C22)
Affinity DataEC50:  26nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580430(US11491148, Compound C31S* | US11491148, Compound ...)
Affinity DataEC50:  31nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580422(US11491148, Compound C28R*)
Affinity DataEC50:  32nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580455(US11491148, Compound C39t)
Affinity DataEC50:  33nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580439(US11491148, Compound C33R* | US11491148, Compound ...)
Affinity DataEC50:  34nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580443(US11491148, Compound C34S*)
Affinity DataEC50:  35nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580444(US11491148, Compound C30R*)
Affinity DataEC50:  37nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580231(US11491148, Compound C5)
Affinity DataEC50:  40nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580440(US11491148, Compound C33S*)
Affinity DataEC50:  40nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580423(US11491148, Compound C28S* | US11491148, Compound ...)
Affinity DataEC50:  42nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580445(US11491148, Compound C35 | US11491148, Compound C3...)
Affinity DataEC50:  43nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580245(US11491148, Compound C6)
Affinity DataEC50:  44nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580284(US11491148, Compound C8)
Affinity DataEC50:  45nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580226(US11491148, Compound C4)
Affinity DataEC50:  53nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580430(US11491148, Compound C31S* | US11491148, Compound ...)
Affinity DataEC50:  56nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580426(US11491148, Compound C30S*)
Affinity DataEC50:  60nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580400(US11491148, Compound C13)
Affinity DataEC50:  61nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580456(US11491148, Compound C39c)
Affinity DataEC50:  62nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580423(US11491148, Compound C28S* | US11491148, Compound ...)
Affinity DataEC50:  70nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580417(US11491148, Compound C25S*)
Affinity DataEC50:  74nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580205(US11491148, Compound C2)
Affinity DataEC50:  79nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580266(US11491148, Compound C7)
Affinity DataEC50:  100nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580191(US11491148, Compound C1)
Affinity DataEC50:  150nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580419(US11491148, Compound C26 | US11491148, Compound C2...)
Affinity DataEC50:  176nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580370(US11491148, Compound C9)
Affinity DataEC50:  204nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580191(US11491148, Compound C1)
Affinity DataEC50:  270nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580397(US11491148, Compound C10)
Affinity DataEC50:  578nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580399(US11491148, Compound C12)
Affinity DataEC50:  1.29E+3nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

TargetCapsid protein(HBV)
Janssen Sciences Ireland

US Patent
LigandPNGBDBM580398(US11491148, Compound C11)
Affinity DataEC50:  1.50E+3nMAssay Description:The anti HBV activity was measured using the HepG2.117 cell line, a stable, inducible HBV producing cell line, which replicates HBV in the absence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
US Patent

Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: